Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | AZN | AMGN | GILD | BMY |
| Company | Alnylam Pharmaceuticals | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 288.09 | 174.24 | 395.03 | 134.41 | 63.87 |
| High | 290.60 | 175.04 | 397.88 | 134.64 | 63.91 |
| Low | 284.15 | 172.63 | 386.58 | 132.57 | 63.10 |
| Latest | 286.62 | 173.30 | 387.64 | 132.73 | 63.10 |
| Change | -1.79 | +0.82 | -5.46 | -1.59 | -0.50 |
| % Change | -0.62% | +0.48% | -1.39% | -1.18% | -0.79% |
| Volume | 1,301,500 | 2,252,200 | 3,005,300 | 7,766,300 | 10,609,200 |
| 20-Day Average Volume | 1,555,020 | 2,920,065 | 2,337,875 | 6,664,665 | 10,447,585 |
| Previous Close | 288.41 | 172.48 | 393.10 | 134.32 | 63.60 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 289.41 | 174.94 | 368.90 | 131.95 | 59.66 |
| 20-Day Raw Stochastic | 20.72% | 28.56% | 76.48% | 49.11% | 78.48% |
| 20-Day Relative Strength | 48.75 | 46.48 | 64.76 | 52.55 | 62.17 |
| Weighted Alpha | -31.37 | +7.84 | +32.72 | +13.64 | +41.53 |
| Today's Opinion | 100% Sell | 88% Sell | 100% Buy | 8% Buy | 72% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 100% Buy | 24% Buy | 72% Buy |
| Last Month's Opinion | 88% Sell | 8% Buy | 56% Buy | 56% Sell | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.35% since 07/22/26 | +2.10% since 07/22/26 | +5.90% since 07/22/26 | +1.83% since 07/22/26 | +3.85% since 07/22/26 |
| Low | 262.21 on 07/23/26 | 166.04 on 07/23/26 | 359.21 on 07/23/26 | 127.61 on 07/23/26 | 60.45 on 07/23/26 |
| High | 290.60 on 07/29/26 | 175.04 on 07/29/26 | 398.00 on 07/28/26 | 136.26 on 07/28/26 | 64.96 on 07/28/26 |
| 1-Month | |||||
| %Chg | -2.35% since 06/29/26 | -9.24% since 06/29/26 | +7.51% since 06/29/26 | +5.07% since 06/29/26 | +7.75% since 06/29/26 |
| Low | 262.21 on 07/23/26 | 164.06 on 07/20/26 | 353.95 on 07/15/26 | 124.19 on 06/30/26 | 56.30 on 07/01/26 |
| High | 380.00 on 07/09/26 | 196.41 on 07/02/26 | 398.00 on 07/28/26 | 140.61 on 07/17/26 | 64.96 on 07/28/26 |
| 3-Month | |||||
| %Chg | -4.84% since 04/29/26 | -6.43% since 04/29/26 | +14.68% since 04/29/26 | +3.02% since 04/29/26 | +9.57% since 04/29/26 |
| Low | 262.21 on 07/23/26 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 380.00 on 07/09/26 | 196.41 on 07/02/26 | 398.00 on 07/28/26 | 140.61 on 07/17/26 | 64.96 on 07/28/26 |
| 6-Month | |||||
| %Chg | -17.35% since 01/29/26 | -6.42% since 01/29/26 | +13.03% since 01/29/26 | -4.89% since 01/29/26 | +16.25% since 01/29/26 |
| Low | 262.21 on 07/23/26 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 380.00 on 07/09/26 | 212.71 on 02/18/26 | 398.00 on 07/28/26 | 157.29 on 02/11/26 | 64.96 on 07/28/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 38,506,484 | 267,500,608 | 212,159,216 | 166,767,680 | 129,875,720 |
| Shares Outstanding, K | 133,513 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 3,713,940,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 313,750,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,167,180,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | 205,990,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.27 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.99 on 04/30/26 | 2.63 on 07/27/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 07/30/26 | 11/05/26 | 08/04/26 | 08/04/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 76.27 | 17.47 | 17.03 | 15.59 | 10.55 |